Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study.

Focà E, Cavaglià G, Rusconi S, Cascavilla A, Cenderello G, Re A, Casari S, van den Bogaart L, Zinzani PL, Caracciolo D, Di Perri G, Bonito A, Lucchini A, Cassola G, Viale P, Calcagno A.

HIV Med. 2018 Jun 4. doi: 10.1111/hiv.12624. [Epub ahead of print]

PMID:
29862615
2.

Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing.

Riccardi N, Giannini B, Borghesi ML, Taramasso L, Cattaneo E, Cenderello G, Toscanini F, Giacomini M, Pontali E, Cassola G, Viscoli C, Di Biagio A.

ERJ Open Res. 2018 Feb 2;4(1). pii: 00108-2017. doi: 10.1183/23120541.00108-2017. eCollection 2018 Jan.

3.

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.

Saracino A, Cozzi-Lepri A, Shanyinde M, Ceccherini Silberstein F, Nozza S, Di Biagio A, Cassola G, Bruno G, Capobianchi M, Puoti M, Monno L, d'Arminio Monforte A; ICONA Foundation Study.

PLoS One. 2018 Jan 11;13(1):e0190302. doi: 10.1371/journal.pone.0190302. eCollection 2018.

4.

Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy.

Sticchi C, Alberti M, Artioli S, Assensi M, Baldelli I, Battistini A, Boni S, Cassola G, Castagnola E, Cattaneo M, Cenderello N, Cristina ML, De Mite AM, Fabbri P, Federa F, Giacobbe DR, La Masa D, Lorusso C, Marioni K, Masi VM, Mentore B, Montoro S, Orsi A, Raiteri D, Riente R, Samengo I, Viscoli C, Carloni R; Collaborative Group for the Point Prevalence Survey of healthcare-associated infections in Liguria.

J Hosp Infect. 2018 May;99(1):8-16. doi: 10.1016/j.jhin.2017.12.008. Epub 2017 Dec 15.

PMID:
29253622
5.

Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.

Cristina ML, Alicino C, Sartini M, Faccio V, Spagnolo AM, Bono VD, Cassola G, De Mite AM, Crisalli MP, Ottria G, Schinca E, Pinto GL, Bottaro LC, Viscoli C, Orsi A, Giacobbe DR, Icardi G; Genoan Klebsiella pneumoniae research group.

J Infect Public Health. 2018 Mar - Apr;11(2):171-177. doi: 10.1016/j.jiph.2017.06.003. Epub 2017 Jun 28.

6.

Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

Di Biagio A, Ameri M, Sirello D, Cenderello G, Di Bella E, Taramasso L, Giannini B, Giacomini M, Viscoli C, Cassola G, Montefiori M.

BMC Infect Dis. 2017 Feb 6;17(1):127. doi: 10.1186/s12879-017-2199-x.

7.

Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy).

Venturini A, Cenderello G, Di Biagio A, Giannini B, Ameri M, Giacomini M, Montefiori M, Setti M, Mazzarello G, Merlano C, Orcamo P, Viscoli C, Cassola G.

AIDS Care. 2017 Nov;29(11):1373-1377. doi: 10.1080/09540121.2017.1286286. Epub 2017 Feb 2.

PMID:
28150510
8.

An unexpected waterborne traveller.

Riccardi N, Cenderello G, Costa M, Cassola G.

Infection. 2017 Jun;45(3):391-392. doi: 10.1007/s15010-016-0979-7. Epub 2017 Jan 6. No abstract available.

PMID:
28063127
9.

Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides.

Di Biagio A, Riccardi N, Taramasso L, Capetti A, Cenderello G, Signori A, Vitiello P, Guerra M, de Socio GV, Cassola G, Quirino T, Viscoli C.

Int J Antimicrob Agents. 2016 Nov;48(5):551-554. doi: 10.1016/j.ijantimicag.2016.07.009. Epub 2016 Aug 17.

PMID:
27566908
10.

Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency.

Cenderello G, Di Biagio A, Riccardi N, Taramasso L, De Maria A, Cassola G, Viscoli C.

New Microbiol. 2016 Oct;39(4):299-300. Epub 2016 Aug 23.

11.

Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection.

Cenderello G, Taramasso L, Riccardi N, Di Biagio A, Cassola G, De Maria A.

Clin Infect Dis. 2016 May 15;62(10):1323. doi: 10.1093/cid/ciw087. Epub 2016 Feb 16. No abstract available.

PMID:
26908811
12.

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation.

Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A.

Clinicoecon Outcomes Res. 2015 Dec 31;8:15-21. doi: 10.2147/CEOR.S93641. eCollection 2016.

13.

Quality of Life Among Hiv Patients: Results from the Ianua Clinical Trial.

Ameri M, Cassola G, Cenderello G, Di Biagio A, Giacomini M, Giannini B, Mazzarello G, Merlano C, Montefiori M, Orcamo P, Setti M, Viscoli C.

Value Health. 2015 Nov;18(7):A592. doi: 10.1016/j.jval.2015.09.1525. Epub 2015 Oct 20. No abstract available.

14.

Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation.

Cenderello G, Artioli S, Gaggero D, Pasa A, Dentone C, Fraguglia C, Giacomini M, Giannini B, Pastorino G, Viscoli C, Cassola G, Di Biagio A.

Value Health. 2015 Nov;18(7):A579-80. doi: 10.1016/j.jval.2015.09.1933. Epub 2015 Oct 20. No abstract available.

15.

Appropriateness Score and Cost Evaluation In Hiv: The Aprosce System, on Field Clinical Evaluation.

Gaggero D, Marra D, Giacomini M, Giannini B, Fraguglia C, Cenderello G, Cassola G.

Value Health. 2015 Nov;18(7):A577. doi: 10.1016/j.jval.2015.09.1920. Epub 2015 Oct 20. No abstract available.

16.

IANUA: a regional project for the determination of costs in HIV-infected patients.

Giannini B, Gazzarata R, Orcamo P, Merlano C, Cenderello G, Venturini A, Di Biagio A, Mazzarello G, Montefiori M, Ameri M, Setti M, Viscoli C, Cassola G, Giacomini M.

Stud Health Technol Inform. 2015;210:241-5.

PMID:
25991142
17.

Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis.

Paparo F, Cenderello G, Revelli M, Bacigalupo L, Rutigliani M, Zefiro D, Cevasco L, Amico M, Bandelloni R, Cassola G, Forni GL, Rollandi GA.

Biomed Res Int. 2015;2015:758164. doi: 10.1155/2015/758164. Epub 2015 Mar 19.

18.

Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts.

Cenderello G, Tittle V, Pasa A, Dentone C, Artioli S, Setti M, Giacomini M, Fraccaro P, Viscoli C, Cassola G, Di Biagio A, Barbour A, Nelson M.

J Infect. 2015 Jun;70(6):690-4. doi: 10.1016/j.jinf.2014.12.009. Epub 2015 Jan 5. No abstract available.

PMID:
25572999
19.

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy.

Cozzi-Lepri A, Antinori A, Bonora S, Cingolani A, Cassola G, Angarano G, Vullo V, Mussini C, Gori A, Maggiolo F, Castagna A; d’Arminio Monforte on behalf of the ICONA Foundation Study, Antonella.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19771. doi: 10.7448/IAS.17.4.19771. eCollection 2014.

20.

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL.

Dentone C, Fenoglio D, Signori A, Cenderello G, Parodi A, Bozzano F, Guerra M, De Leo P, Bartolacci V, Mantia E, Orofino G, Kalli F, Marras F, Fraccaro P, Giacomini M, Cassola G, Bruzzone B, Ferrea G, Viscoli C, Filaci G, De Maria A, Di Biagio A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014.

21.

Quality of life of people living with HIV, preliminary results from IANUA (Investigation on Antiretroviral Therapy) study.

Venturini A, Giannini B, Montefiori M, Di Biagio A, Mazzarello G, Cenderello G, Giacomini M, Merlano C, Orcamo P, Setti M, Viscoli C, Cassola G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19581. doi: 10.7448/IAS.17.4.19581. eCollection 2014.

22.

Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure.

Rozera G, Abbate I, Giombini E, Castagna A, De Luca A, Ceccherini-Silberstein F, Cozzi Lepri A, Cassola G, Torti C, d'Arminio Monforte A, Ippolito G, Capobianchi MR; ICONA Foundation Group.

J Antimicrob Chemother. 2014 Nov;69(11):3085-94. doi: 10.1093/jac/dku255. Epub 2014 Jul 10.

PMID:
25015667
23.

Real-time elastography in the assessment of liver fibrosis: a review of qualitative and semi-quantitative methods for elastogram analysis.

Paparo F, Corradi F, Cevasco L, Revelli M, Marziano A, Molini L, Cenderello G, Cassola G, Rollandi GA.

Ultrasound Med Biol. 2014 Sep;40(9):1923-33. doi: 10.1016/j.ultrasmedbio.2014.03.021. Epub 2014 Jun 25. Review.

24.

Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.

Nicolini LA, Taramasso L, Schiavetti I, Giannini EG, Beltrame A, Feasi M, Cassola G, Grasso A, Bartolacci V, Sticchi L, Picciotto A, Viscoli C; Ligurian HBV Study Group.

Antivir Ther. 2015;20(2):193-7. doi: 10.3851/IMP2819. Epub 2014 Jun 25.

PMID:
24963642
25.

Therapeutic management of chronic hepatitis B in clinical practice: a region-wide survey.

Giannini EG, Marenco S, Boni S, Beltrame A, Nicolini LA, Taramasso L, Feasi M, Grasso A, De Leo P, Percario G, Bartolacci V, Artioli S, Viscoli C, Cassola G, Testa R, Anselmo M, Riccio G, Savarino V, Picciotto A; Ligurian Hepatitis B Virus Study Group.

J Clin Gastroenterol. 2015 Mar;49(3):228-34. doi: 10.1097/MCG.0000000000000106.

PMID:
24583753
26.

An unexpected Streptococcus pneumoniae strain.

Cenderello G, Pontali E, Torresin A, Milano G, Ansaldi F, Feasi M, Usiglio D, Mori M, Icardi G, Cassola G.

J Chemother. 2014 Jun;26(3):173-5. doi: 10.1179/1973947813Y.0000000125. Epub 2013 Dec 6.

PMID:
24090710
27.

Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy.

Cenderello G, Pasa A, Dusi A, Dentone C, Toscanini F, Bobbio N, Bondi E, Del Bono V, Izzo M, Riccio G, Anselmo M, Giacchino R, Marazzi MG, Pagano G, Cassola G, Viscoli C, Ferrea G, De Maria A.

BMC Infect Dis. 2013 May 30;13:248. doi: 10.1186/1471-2334-13-248.

28.

Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.

Antonucci G, Mazzotta F, Angeletti C, Girardi E, Puoti M, De Stefano G, Grossi P, Petrosillo N, Pagano G, Cassola G, Orani A, Sagnelli C, Armignacco O, Sagnelli E; Coorte Epatiti B SIMIT/COESI-B (HIV) Group.

BMC Res Notes. 2013 Apr 17;6:153. doi: 10.1186/1756-0500-6-153.

29.

Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports.

Cenderello G, Pontali E, Cassola G, Torresin A.

Infection. 2013 Feb;41(1):199-202. doi: 10.1007/s15010-012-0353-3. Epub 2012 Oct 14.

PMID:
23065464
30.

Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome.

d'Arminio Monforte A, Cozzi-Lepri A, Girardi E, Castagna A, Mussini C, Di Giambenedetto S, Galli M, Cassola G, Vullo V, Quiros-Roldan E, Lo Caputo S, Antinori A; Icona Foundation Study Group.

Antivir Ther. 2011;16(7):1103-12. doi: 10.3851/IMP1883.

PMID:
22024526
31.

Severe fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluation.

Giorgio E, Caroti C, Mattioli F, Uliana V, Parodi MI, D'Amico M, Fucile C, Marini V, Forzano F, Cassola G, Martelli A, Faravelli F, Di Maria E.

Cancer Chemother Pharmacol. 2011 Nov;68(5):1355-61. doi: 10.1007/s00280-011-1709-6. Epub 2011 Aug 11.

PMID:
21833589
32.

Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort.

Vescini F, Cozzi-Lepri A, Borderi M, Re MC, Maggiolo F, De Luca A, Cassola G, Vullo V, Carosi G, Antinori A, Tozzi V, Monforte AD; Icona Foundation Study Group.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):163-72. doi: 10.1097/QAI.0b013e31822e57e9.

PMID:
21826011
33.

Gastrointestinal bleeding due to suspected anisakiasis: challenging differential diagnosis for a rare disease.

Filauro M, Rollandi GA, Cassola G, Quilici P, Angelini G, Belli F, Boccardo C.

Updates Surg. 2011 Sep;63(3):213-7. doi: 10.1007/s13304-011-0055-x. Epub 2011 Mar 29.

PMID:
21445646
34.

Guillain-Barré Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report.

Pontali E, Feasi M, Crisalli MP, Cassola G.

Case Rep Infect Dis. 2011;2011:972096. doi: 10.1155/2011/972096. Epub 2011 Jul 2.

35.

Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008.

Prosperi MC, Cozzi-Lepri A, Antinori A, Cassola G, Torti C, Ursitti MA, Pellizzer GP, Giacometti A, d'Arminio Monforte A, De Luca A; Icona Foundation Study Group.

HIV Med. 2011 Mar;12(3):174-82. doi: 10.1111/j.1468-1293.2010.00866.x. Epub 2010 Aug 18.

36.

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia.

Svicher V, Alteri C, Gori C, Salpini R, Marcuccilli F, Bertoli A, Longo R, Bernassola M, Gallinaro V, Romano S, Visca M, Ursitti A, Feasi M, Micheli V, Angelico M, Cassola G, Parruti G, Gubertini G, De Sanctis GM, Ceccherini-Silberstein F, Cappiello G, Spanò A, Perno CF.

Dig Liver Dis. 2010 Dec;42(12):902-7. doi: 10.1016/j.dld.2010.04.017. Epub 2010 Jun 19.

PMID:
20621632
37.

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures.

Trotta MP, Cozzi-Lepri A, Ammassari A, Vecchiet J, Cassola G, Caramello P, Vullo V, Soscia F, Chiodera A, Ladisa N, Abeli C, Cauda R, Buonuomi AR, Antinori A, d'Arminio Monforte A; ICONA Foundation Study.

Clin Infect Dis. 2010 Aug 15;51(4):456-64. doi: 10.1086/655151.

PMID:
20597690
38.

Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy.

Bassetti M, Parisini A, Calzi A, Pallavicini FM, Cassola G, Artioli S, Anselmo M, Pagano G, Rezza G, Viscoli C; Ligurian H1N1 Collaborative Group.

Clin Microbiol Infect. 2011 Feb;17(2):247-50. doi: 10.1111/j.1469-0691.2010.03275.x.

39.

Tick-borne encephalitis (TBE) during a "grand-tour" of Europe clinically manifesting in a TBE-free region.

Pontali E, Bobbio N, Cassola G.

J Travel Med. 2010 Mar-Apr;17(2):143-5. doi: 10.1111/j.1708-8305.2009.00383.x.

40.

Surgical site infections in HIV-infected patients: results from an Italian prospective multicenter observational study.

Drapeau CM, Pan A, Bellacosa C, Cassola G, Crisalli MP, De Gennaro M, Di Cesare S, Dodi F, Gattuso G, Irato L, Maggi P, Pantaleoni M, Piselli P, Soavi L, Rastrelli E, Tacconelli E, Petrosillo N.

Infection. 2009 Oct;37(5):455-60. doi: 10.1007/s15010-009-8225-1.

PMID:
20358638
41.

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.

Cicconi P, Cozzi-Lepri A, Castagna A, Trecarichi EM, Antinori A, Gatti F, Cassola G, Sighinolfi L, Castelli P, d'Arminio Monforte A; ICoNA Foundation Study Group.

HIV Med. 2010 Feb;11(2):104-13. doi: 10.1111/j.1468-1293.2009.00750.x. Epub 2009 Sep 1.

42.

Erysipelothrix rhusiopathiae intra-abdominal abscess.

Feasi M, Bacigalupo L, Cappato S, Pontali E, Usiglio D, Rollandi GA, Filauro M, Mori M, Cassola G.

Int J Infect Dis. 2010 Jan;14(1):e81-3. doi: 10.1016/j.ijid.2009.03.008. Epub 2009 May 29.

43.

Imported typhoid fever with hepatitis from Bangladesh: a case of delayed response to ceftriaxone?

Pontali E, Feasi M, Usiglio D, Mori M, Cassola G.

J Travel Med. 2008 Sep-Oct;15(5):366-8. doi: 10.1111/j.1708-8305.2008.00239.x.

44.

Hepatitis B reactivation prophylaxis in immune-suppressed patients.

Torresin A, Feasi M, Cassola G.

Haematologica. 2008 Nov;93(11):e65. doi: 10.3324/haematol.13498. No abstract available.

45.

Lymphoma and human immunodeficiency virus (HIV) infection: another favourable setting?

Torresin A, Feasi M, Cassola G.

Ann Oncol. 2007 Aug;18(8):1422-3. No abstract available.

PMID:
17693657
46.

Hepatitis B serological evaluation in diagnostic work up of lymphoma.

Torresin A, Feasi M, Cassola G.

Ann Oncol. 2007 Jul;18(7):1284. No abstract available.

PMID:
17675399
47.

Vinca alkaloids and macrolides in human immunodeficiency virus-related malignancies: a safe association.

Torresin A, Cassola G, Penco G, Crisalli MP, Piersantelli N.

Cancer Chemother Pharmacol. 1996;39(1-2):176-7. No abstract available.

PMID:
8995518
48.

[Rhodococcus equi infections in AIDS: personal cases].

Piersantelli N, Casini-Lemmi M, Cavanna E, Cassola G, Crisalli MP, Guida B, Paladino M, Penco G, Piscopo R, Torresin A.

Pathologica. 1992 Jul-Aug;84(1092):517-21. Italian.

PMID:
1491893
49.

[Esophageal ulcer caused by Geotrichum candidum in a case of AIDS].

Tricerri R, Oppezzi M, Dodero M, Piersantelli N, Guida B, Cassola G.

Pathologica. 1990 Mar-Apr;82(1078):187-91. Italian.

PMID:
2392339

Supplemental Content

Loading ...
Support Center